Issue 3, 2024

Covalent drugs based on small molecules and peptides for disease theranostics

Abstract

Biomacromolecules, such as proteins, nucleic acids and polysaccharides, are widely distributed in the human body, and some of them have been recognized as the targets of drugs for disease theranostics. Drugs typically act on targets in two ways: non-covalent bond and covalent bond. Non-covalent bond-based drugs have some disadvantages, such as structural instability and environmental sensitivity. Covalent interactions between drugs and targets have a longer action time, higher affinity and controllability than non-covalent interactions of conventional drugs. With the development of artificial intelligence, covalent drugs have received more attention and have been developed rapidly in pharmaceutical research in recent years. From the perspective of covalent drugs, this review summarizes the design methods and the effects of covalent drugs. Finally, we discuss the application of covalent peptide drugs and expect to provide a new reference for cancer treatment.

Graphical abstract: Covalent drugs based on small molecules and peptides for disease theranostics

Article information

Article type
Review Article
Submitted
07 iyl 2023
Accepted
04 noy 2023
First published
08 noy 2023

Biomater. Sci., 2024,12, 564-580

Covalent drugs based on small molecules and peptides for disease theranostics

Y. Zhang, J. Liang, Y. Xu, Y. Liu, Y. Cui, Z. Qiao and H. Wang, Biomater. Sci., 2024, 12, 564 DOI: 10.1039/D3BM01138K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements